1. Home
  2. List
Reference Patent

Reference - List

  • 27 Hits
  • Search Condition : Filter (MeSH = Cholangiocarcinoma / metabolism)
Species Resource Title
Human and Animal Cells HuCCT1(RCB1960) BEX2 is required for maintaining dormant cancer stem cell in hepatocellular carcinoma.
Human and Animal Cells G-415(RCB2640) Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , TFK-1(RCB2537) Extracellular RNA transfer from non-malignant human cholangiocytes can promote cholangiocarcinoma growth.
Human and Animal Cells SSP-25(RCB1293), RBE(RCB1292) Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
Human and Animal Cells HuCCT1(RCB1960) , TFK-1(RCB2537) , HuH-28(RCB1943) E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma.
Human and Animal Cells SSP-25(RCB1293) Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter.
Human and Animal Cells SSP-25(RCB1293) Autophagy Plays a Role in the CUL4A-Related Poor Prognosis of Intrahepatic Cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice.
Human and Animal Cells Hep G2(RCB1648) , HuH-7(RCB1366) The overexpression of polycomb group proteins Bmi1 and EZH2 is associated with the progression and aggressive biological behavior of hepatocellular carcinoma.
Human and Animal Cells SSP-25(RCB1293) , TFK-1(RCB2537) Anti-Glypican-1 Antibody-drug Conjugate as Potential Therapy Against Tumor Cells and Tumor Vasculature for Glypican-1-Positive Cholangiocarcinoma.
Human and Animal Cells HuCCT1(RCB1960) IDH1 mutation correlates with a beneficial prognosis and suppresses tumor growth in IHCC.
Human and Animal Cells HuCCT1(RCB1960) Ubiquitin-conjugating enzyme E2T regulates cell proliferation and migration in cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) , HuH-28(RCB1943) Integrin β3 and LKB1 are independently involved in the inhibition of proliferation by lovastatin in human intrahepatic cholangiocarcinoma.
Human and Animal Cells TGBC1TKB(RCB1129) p38delta/MAPK13 as a diagnostic marker for cholangiocarcinoma and its involvement in cell motility and invasion.
Human and Animal Cells SSP-25(RCB1293) , HuH-28(RCB1943) CXCL12 expression in intrahepatic cholangiocarcinoma is associated with metastasis and poor prognosis.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) Loss of ARID1A induces a stemness gene ALDH1A1 expression with histone acetylation in the malignant subtype of cholangiocarcinoma.
Human and Animal Cells HuH-28(RCB1943) Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity.
Human and Animal Cells TFK-1(RCB2537) Mitochondrial pyruvate carrier modulates the epithelial-mesenchymal transition in cholangiocarcinoma.
Human and Animal Cells HuCCT1(RCB1960) , RBE(RCB1292) GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma.
Human and Animal Cells RBE(RCB1292) CD90 expression in human intrahepatic cholangiocarcinoma is associated with lymph node metastasis and poor prognosis.